Intersect ENT
XENT
#5963
Rank
โ‚ฌ0.83 B
Marketcap
24,64ย โ‚ฌ
Share price
0.00%
Change (1 day)
11.81%
Change (1 year)

Revenue for Intersect ENT (XENT)

Revenue in 2021: โ‚ฌ93.13 Million

According to Intersect ENT's latest financial reports the company's current revenue (TTM ) is โ‚ฌ93.13 Million. In 2021 the company made a revenue of โ‚ฌ93.13 Million an increase over the revenue in the year 2020 that were of โ‚ฌ70.28 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Intersect ENT from 2012 to 2021

Annual revenue

Year Revenue Change
2021โ‚ฌ93.13 M32.52%
2020โ‚ฌ70.28 M-26.19%
2019โ‚ฌ95.22 M0.62%
2018โ‚ฌ94.64 M12.64%
2017โ‚ฌ84.02 M22.35%
2016โ‚ฌ68.67 M27.79%
2015โ‚ฌ53.73 M59.62%
2014โ‚ฌ33.66 M115.2%
2013โ‚ฌ15.64 M205.83%
2012โ‚ฌ5.11 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Ocular Therapeutix
OCUL
โ‚ฌ48.67 M-47.74%๐Ÿ‡บ๐Ÿ‡ธ USA
ICON plc
ICLR
โ‚ฌ7.06 B 7,490.40%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Anika Therapeutics
ANIK
โ‚ฌ70.59 M-24.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Haemonetics
HAE
โ‚ฌ1.15 B 1,143.91%๐Ÿ‡บ๐Ÿ‡ธ USA